Representative Matter

Checkpoint Therapeutics Prices Secondary Public Offering

Representation as underwriters’ counsel of National Securities Corporation, as representative of the underwriting syndicate, in connection with a secondary public offering of common stock by Checkpoint Therapeutics, Inc. (Nasdaq: CKPT), a clinical-stage immune-oncology biopharmaceutical company.